Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | myeloid cell leukemia 1 | Starlite/ChEMBL | No references |
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Homo sapiens | sphingomyelin phosphodiesterase 1, acid lysosomal | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed), eta | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific demethylase 4E | Starlite/ChEMBL | No references |
Homo sapiens | huntingtin | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.01 | 0.0384 | 0.0368 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.0017 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.01 | 0.0384 | 0.0368 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0052 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0185 | 0.0185 |
Brugia malayi | hypothetical protein | 0.003 | 0.0052 | 0.0052 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.01 | 0.0384 | 0.0368 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.0017 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0052 | 0.2319 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.1272 | 0.1257 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0596 | 0.0596 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0017 | 0.5 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.0856 | 0.3999 | 0.3989 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.01 | 0.0384 | 0.0368 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0054 | 0.0165 | 1 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.0017 | 0.0017 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.1272 | 0.1257 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0038 | 0.0088 | 1 |
Schistosoma mansoni | DNA polymerase eta | 0.0054 | 0.0165 | 0.0147 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0054 | 0.0165 | 0.0165 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0054 | 0.0165 | 1 |
Schistosoma mansoni | apoptosis regulator bax | 0.01 | 0.0384 | 0.0368 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0038 | 0.0088 | 0.4775 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.4591 | 0.4581 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.0614 | 0.0437 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0052 | 0.2319 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0071 | 0.0246 | 0.0229 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0071 | 0.0246 | 0.0229 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0885 | 0.0869 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0165 | 0.0147 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.01 | 0.0384 | 0.0368 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.211 | 1 | 1 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.01 | 0.0384 | 0.0368 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0071 | 0.0246 | 0.0229 |
Leishmania major | DNA polymerase eta, putative | 0.0038 | 0.0088 | 0.4775 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0596 | 0.0579 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.0614 | 0.0437 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.0017 | 0.5 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.01 | 0.0384 | 0.0384 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0614 | 0.0597 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0052 | 0.2319 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0885 | 0.0869 |
Schistosoma mansoni | hypothetical protein | 0.01 | 0.0384 | 0.0368 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.0017 | 0.5 |
Schistosoma mansoni | jumonji domain containing protein | 0.0071 | 0.0246 | 0.0229 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0596 | 0.0579 |
Schistosoma mansoni | sodium-bile acid cotransporter | 0.1254 | 0.5907 | 0.59 |
Echinococcus granulosus | geminin | 0.0205 | 0.0885 | 0.0869 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0017 | 0.5 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0071 | 0.0246 | 0.0229 |
Echinococcus multilocularis | geminin | 0.0205 | 0.0885 | 0.0869 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0614 | 0.0597 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.0246 | 0.0229 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.0383 | 0.0366 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.0017 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0052 | 0.2319 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0185 | 0.0167 |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.0246 | 0.0246 |
Onchocerca volvulus | 0.211 | 1 | 1 | |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0185 | 0.0167 |
Loa Loa (eye worm) | hypothetical protein | 0.211 | 1 | 1 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0054 | 0.0165 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0052 | 0.0034 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0071 | 0.0246 | 0.0229 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.1272 | 0.1257 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0286 | 0.1272 | 0.1272 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.01 | 0.0383 | 1 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0071 | 0.0246 | 0.0246 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.0384 | 0.0368 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.01 | 0.0383 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.0054 | 0.0165 | 0.0147 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0052 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.0054 | 0.0165 | 0.0147 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.01 | 0.0384 | 0.0368 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.211 | 1 | 1 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.01 | 0.0384 | 0.0368 |
Brugia malayi | hypothetical protein | 0.0148 | 0.0614 | 0.0614 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0071 | 0.0246 | 0.0229 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0052 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 2.109717268 um | PUBCHEM_BIOASSAY: Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors. (Class of assay: confirmatory) [Related pubchem assays: 1022 (Primary screen preceding this dose-response assay.)] | ChEMBL. | No reference |
IC50 (functional) | 30.65 uM | PubChem BioAssay. Dose response confirmation of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (binding) | = 40 uM | Inhibition of BLM (unknown origin) by gel-based DNA unwinding assay | ChEMBL. | 24012121 |
IC50 (functional) | 80 uM | PubChem BioAssay. Dose response confirmation of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, in an orthogonal absorbance-based assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.4147 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 1 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 1.9953 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 3.6626 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.